Editing Cannabinoid receptor (section)

== Cannabinoid treatments ==
{{main|Medical cannabis}}
Synthetic [[tetrahydrocannabinol]] (THC) is prescribed under the [[International Nonproprietary Name|INN]] ''dronabinol'' or the brand name ''Marinol'', to treat [[vomiting]] and for enhancement of [[appetite]], mainly in people with [[AIDS]] as well as for refractory [[nausea]] and [[vomiting]] in people undergoing [[chemotherapy]].<ref>{{cite journal | vauthors = Badowski ME | title = A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics | journal = Cancer Chemotherapy and Pharmacology | volume = 80 | issue = 3 | pages = 441–449 | date = September 2017 | pmid = 28780725 | pmc = 5573753 | doi = 10.1007/s00280-017-3387-5 }}</ref> Use of synthetic THC is becoming more common as the known benefits become more prominent within the medical industry. THC is also an [[active pharmaceutical ingredient|active ingredient]] in [[nabiximols]], a specific extract of ''[[Cannabis]]'' that was approved as a [[botanical drug]] in the United Kingdom in 2010 as a mouth spray for people with [[multiple sclerosis]] to alleviate [[neuropathic pain]], [[spasticity]], [[overactive bladder]], and other symptoms.<ref>{{cite web|title=Sativex Oromucosal Spray - Summary of Product Characteristics|url=http://www.medicines.org.uk/emc/medicine/23262|publisher=UK Electronic Medicines Compendium|language=en|date=March 2015|access-date=2017-10-09|archive-url=https://web.archive.org/web/20160822231728/http://www.medicines.org.uk/emc/medicine/23262|archive-date=2016-08-22|url-status=dead}}</ref>